Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Neoplasm Micrometastasis 1Melanoma 1Lymphatic Metastasis 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

Indocyanine Green 7Lymph Node Excision 6Surgical Procedures, Operative 5Radiotherapy, Intensity-Modulated 4Radiotherapy 4Radiosurgery 4Magnetic Resonance Spectroscopy 4Cisplatin 4Specimen Handling 3gadofosveset trisodium 2Technetium 2TP protocol 2Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Nivolumab 2Ipilimumab 2Electroporation 2Conversion to Open Surgery 2Control Groups 2Chemotherapy, Adjuvant 2Chemoradiotherapy 2Artificial Intelligence 2tislelizumab 1sarcolipin 1radium Ra 223 dichloride 1peposertib 1pembrolizumab 1lncRNA LNMAT1, human 1gewf solution 1fluoroazomycin arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × sarcolipin × Clear all
NCT04403867 2022-08-17

ITCMicroUtCa

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Recruiting
500 enrolled
Gynecologic

Uterine Cervical Neoplasms, Lymphatic Metastasis, Endometrial Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡